2006 CMSC Annual Meeting
Celebrating 20 Years of Excellence in MS Care and Research
May 31 - June 3, 2006
Westin Kierland Resort & Spa
Scottsdale, AZ

Note: All the presentations were converted to Adobe PDF. Copying and editing functions were disabled. If you don"t have Adobe Reader, please go to www.adobe.com for a free download.

Dinners Fundamentals Lectures
Symposia Workshops Clinical Courses Whitaker

1. Dinners (Go back to top)
1. Update on Current Rehabilitation Research (IOMSRT)
   Patricia Provance, PT, MSCS and Susan Bennett, PT, EdD, NCS, MSCS
2. High Dose Immunosupression with Stem Cell Rescue: Are We Doing it Right?
   George Kraft, MD, MS
   • Is this a Treatment for MS?
     Richard Nash, MD
   • Are We Giving Adequate Immunosupression?
     Mark Freedman, MD
2. Fundamentals of Multiple Sclerosis Care and Management: Diagnosis to Rehabilitation (Go back to top)
   • Overview of Multiple Sclerosis
     Stephen Rosenberg, MD, FAAN
   • Disease Modifying Therapies and Relapse Management
     Ben Thrower, MD
   • Symptom Management in MS
     Tracy Walker, FNP-C
   • Empowerment in Multiple Sclerosis
     Patricia Kennedy, RN, CNP, MSCN
   • Psychosocial Impact on Multiple Sclerosis
     Cathy-Lee Benbow, MSW, RSW
   • Principles of MS Rehabilitation
     Patricia Bobryk, MHS, PT, MSCS
   • Cognitive, Swallowing and Speech Issues in MS
     Bonnie Schaude, MACCC-SLP
   1. Lectures (Go back to top)
   • Opening Ceremony and Lunch
     The CMSC at 20 Years: Looking Back as We Look Ahead
     Jock Murray, OC, MD, FRCPC, MACP
   • Research Lecture
     A Celebration of Achievements in MS
     Richard Rudick, MD
   • North American Research Committee on Multiple Sclerosis: Past, Present and Future
     Denise Campagnolo, MD, MS
   • LACTRIMS Lecture
     Pathogenesis of Multiple Sclerosis
     Jorge Correale, MD
   • Donald Paty Research Lecture
     Combination Therapy in MS
     Fred Lublin, MD
   2. Symposia (Go back to top)
   1. A Comprehensive Focus on Complex Issues in MS
      Richard Rudick, MD
   • Management of Disease Activity Despite Standard Therapy
     Robert Fox, MD
   • An Update on the Status of Tysabri
     Peter Calabresi, MD
   • Disease Modification in MS: Decision Making.... A Cancer Model
     Michael Kattan, PhD
   2. The Heuga Approach to Overall Health Promotion
      Brian Hutchinson, PT, MSCS
   • Integrating Wellness
     Patricia Kennedy, RN, CNP, MSCN
   • The Next Step: Understanding Motivation to Exercise
     David Engstrom, PhD, ABPP
   • The Importance of Physical Activity in Managing People with MS
     Brian Hutchinson, PT, MSCS
   3. Pediatric Multiple Sclerosis
      Brenda Banwell, MD
      • What's New in Pediatric MS
        Brenda Banwell, MD
      • Predictors of MS: Studies of Acute Demyelination in Children in France
        Prof. Marc Tardieu
      • Perceptions of MS in Children and Teens
        Jennifer Boyd, RN, MHSc, MSCN
      • Resources to Support Children and Teens with MS and their Families (Part 1 & 2)
        Jon Temme
      • The Cognitive Seuelae of MS in Children
        William MacAllister, PhD
   4. Unconventional Medicine and MS: Past, Present and Future
      Allen Bowling, MD, PhD
      • The Past - A Historical Approach to Unconventional Medicine and MS
        Jock Murray, MD
      • The Present - Current Dietary Supplement Use in People wiht MS
        Allen Bowling, MD, PhD
      • The Present - Marijuana, Cannabinoids and MS
        Claude Vaney, MD
      • The Future - Research in CAM and MS
        Vijayshree Yadav, MD
   5. Surviving Cognitive Impairment in MS: Interactive Case Presentations
      Jeffrey Wilken PhD and Mary Elizabeth Quig, PhD
      • Introduction and Description of Symposium Goals
        Jeffrey Wilken PhD and Mary Elizabeth Quig, PhD
      • Areas of Cognition Affected by MS
        Jeffrey Wilken, PhD
      • Review of Correlation Between NeuroImaging and Cognition
        Mary Elizabeth Quig, PhD
      • Review of Latest Pharmacological Treatment Options
        Cynthia Sullivan, PhD
      • Identifying and Working with Cognitive Problems in the Neurologist's Office
        Howard Rossman, DO and Sonda Lawson, MA
      • Interactive Development of a Paradigm to Help MS Patients Survive Cognitive Problems
        Jeffrey Wilken PhD and Mary Elizabeth Quig, PhD
   6. Biomarkers in MS
      Claude Genain, MD
      • Emerging Value of Autoantibodies as Disease Markers in MS
        Claude Genain, MD
      • Biological Markers for Pathophysiological Processes in MS
        Thomas Berger, Prof, MD, MSc
      • Serum Biomarkers of Disease of Activity: Role of Antibodies to Glycoconjugates
        Mark Freedman, MD
      • Through the Eyes of a Child: Insights Obtained from Immunological Studies in Pediatric MS
        Brenda Banwell, MD
   7. Assessment and Management of Disorders of Ambulation in MS
      Francoise Bethoux, MD
      • Ambulation and Gait Disorders in MS
        Francois Bethoux, MD
      • Assessment and Rehabilitation of Gait Disorders in MS
        Matthew Sutliff, PT
      • Use of Lower Extremity Orthoses in MS
        Jonathan Naft, CPO
   8. The Basics of MS Nursing
      Carol Saunders, BA, BSN, MSCN
      • Optimal Nursing Care in MS
        Carol Saunders, BA, BSN, MSCN
      • Networking for Optimum Care
        Carol Chiefee, RN
      • Treatment Adherence in Your Center
        Dorothea Cassidy Pfohl, RN, MSCN
   9. New Challenges to Clinical Trial Design and Implementation
      Fred Lublin, MD
      • New Challenges
        Fred Lublin, MD
      • Recruiting for Clinical Trials - Use of the NARCOMS Database
        Timothy Vollmer, MD
      • Neuroprotective Clinical Trials
        Peter Calabresi, MD
      • Recruitment for Multi-Center Trials, MS CORE
        Steven Schwid, MD
   10. Evaluation and Treatment of Balance Dysfunction in MS
       Susan Bennett, PT, EdD, NCS, MSCS
       • Introduction to the Examination
         Susan Bennett, PT, EdD, NCS, MSCS
       • Evaluation and Treatment of Trunk Instability and Proximal Weakness/Spasticity in MS
         Matthew Sutliff, PT
       • Evaluation and Treatment of Vestibulo Ocular Dysfunction in MS
         Susan Bennett, PT, EdD, NCS, MSCS
       • Oculomotor System: Functional Contribution to Balance
         Sherry Card, OTR/L, BCN
       • Outcome Measures to Establish Evidence for Balance Retraining
         Matthew Sutliff, PT and Susan Bennett, PT, EdD, NCS, MSCS
   11. Progressive MS
       Christopher Bever, Jr., MD, MBA
       • Monitoring Disease with NeuroImaging: Correlates of Visual Dysfunction
         Robert Shin, MD
       • Epidemiology: Cigarettes, Sun, Viruses and Grandparents
         Mitchell Wallin , MD, MPH
       • Symptomatic Management: Potassium Channel Blockers
         Christopher Bever, Jr., MD, MBA
       • Immunosupression: Low Dose Versus Immunoablation
         James Bowen, MD
       • Neuroprotection: A New Therapeutic Approach for Progressive Disease
         Albert Lo, MD
       • The Chronic Disease Management Model in MS: Electronic Medical Record Enhancement
         Jodie Haselkorn, MD, MPH
   12. Immunosurveillance in MS
       Dan Mikol, MD, PhD and Mark Freedman, MD
       • Experimental Novel MS Therapies: Targeted Approaches in Steinman
         Douglas Goodin, MD
       • Ethical Issues in the Treatment of MS
         Gary Birnbaum, MD
       • Progressive Multifocal Leukoencephalopathy and Tysabri
         Joseph Berger, MD
       • Approaches to Polypharmacy
         Mark Freedman, MD
       • Switching Strategies
   13. LACTRIMS 2006
       New Regional Epidemiological Data, Optico-Spinal Forms and "Genetic" Interferons
       Victor Rivera, MD
       • Regional Forms of Optic-Spinal MS
         Marco Lana-Peixoto, MD (Brazil)
       • MS Economic Impact in Health Systems
         Arnold Soto, MD (Venezuela)
       • The Specter of "Generic" Interferons
         Victor Rivera, MD (USA)
       • Recent Data from Peru
         Augusto Martinez, MD (Peru)
       • Recent Data from Chile
         Jorge Barahona, MD (Chile)
   14. Advanced Practice Nursing in MS: Skills for Day to Day Clinical Practice
       Linda Morgante, RN, MSN, CRRN, MSCN
       • Tips for Successfully Completing the Neuro Exam
         Julia Klein, MSN, FNP-C, MSCN
       • Differential Diagnosis: Interpreting MRIs
         Lael Stone, MD
       • Choosing the Right Therapy at the Right Time
         Stephen Kamin, MD
       • Complex Symptom Management: Tremor
         Lynn McEwan, RN, MScN, CNNc, MSCN
       • Decision Making: Considerations in MS Care and Treatment
         Diane Lowden, N.MSc(A), MSCN
   3. Workshops (Go back to top)
   1. Powerpint - Intermediate
      Canceled
   2. From Apathy to Action - An MS Perspective from Across the Oceans
      Nicki Ward, RN, RGN, MSCN, BSc
      • Overview of MS Services in the UK
        Nicki Ward, RN, RGN, MSCN, BSc
      • The Concept of the Expert Patient - MS Nursing in Australia
        Tim O'Maley, RN, BN, CNN
      • Educational Strategies for People with MS
      • Educational Strategies for Professionals
   3. Case-Based Rehabilitation Assessment
      Christine Smith, OTR/L, MSCS; Jason Kavountzis, MPT, OCS; Myra Madlansacay, MA, CCC-SLP
   4. Differing Perspectives on MS Care: A Lively Case-Based Panel Discussion
      James Bowen, MD
      • Neurologist
        Vijayshree Yadav, MD
      • Physical Therapist
        Cinda Hugos, MS, PT
      • Psychologist
        Jeffrey Wilken, PhD
      • Physiatrist
        Donna Jo Blake, MD
      • Nurse Practitioner
        Anne Bateman, RN, MSN, CNP, CRRN
      • Patient Representative
        Artie Guerrero
   5. Sleep Disorders in MS
      David Brandes, MS, MS
   6. Female Sexual Function: The Good, the Bad and the Ugly
      Margie O'Leary, MSN, RN, MSCN
      • What is Good Sexual Function?
        Margie O'Leary, MSN, RN, MSCN
      • Physical Therapy and Assistive Devices Can Improve Sexual Function
        Susan George, PT, MS
      • Sexual Abuse is Ugly: How You Can Help
        Anne Mageras, BSW
   7. Ethnocultural Concerns
      Victor Rivera, MD
      • The Latin American Patient
        Flavia Nelson, MD
      • The Muslim Patient
        Sarah Aisha Khan
      • The African American Perspective
        Mary Hughes, MD
   8. Diagnostic Dilemmas - MS Diagnostic Issues and Masquerades
      Patricia Coyle, MD
   9. Powerpoint - Advanced
      Canceled
   10. Pain Management in MS
       Heidi Maloni, DNScc, RN, CNRN, ANP, MSCN
   11. Sexuality and MS
       Fred Foley, PhD
   12. Healing Ourselves While Healing Others
       Cathy-Lee Benbow, MSW, RSW and Eunice Gorman, RN, BSW, MSW, PhD
   13. MS Coalition Resources - A Hands-on Approach
       MSAA; MSF; CMSC
   14. Pulmonary Rehabilitation in MS
       Jodie Haselkorn, MD, MPH
       • Pulmonary Complications in MS
         Jodie Haselkorn, MD, MPH
       • Assessment and Management of Pulmonary Impairments in MS
         Richard Goodman, MD
       • Pulmonary Rehabilitation in MS
         Donna Fry, PT, PhD
       • Respiratory Muscle Training - Effect on Pulmonary Function, Cough and Components of Speech
         Toni Chiara, PhD, PT
   15. Management of Major Depressive Disorder in Multiple Sclerosis
       Dawn Ehde, PhD
       • Management of MDD in MS: Diagnostic, Conceptual and Access Issues
         Dawn Ehde, PhD
       • Pharmacological Management of MDD
         Lydia Chwastiak, MD, MPH
       • Psychological Interventions for MDD
         David Mohr, PhD
   16. Legal Issues for Professional Nurses
       Linda Morgante, RN, MSN, CRRN, MSCN
       • When the Scales of Justice Tip
         Deidre Robokos, Esq
       • Exact, Brief and Truthful: Handling the EBT
         Marie Namey, RN, MSN, MSCN
       • Testifying for the Defense
         Linda Morgante, RN, MSN, CRRN, MSCN
   17. Osteoporosis and MS: Current Strategies for Improving Skeletal Health
       Bianca Weinstock-Guttman, MD
       • Incidence, Risk Factors and Medical Management of Osteoporosis in MS Patients
         Bianca Weinstock-Guttman, MD
       • Pathophysiology of Osteoporosis and Effect of IFN in Bone Homestasis
         Murali Ramanathan, PhD
       • Diagnostic Procedures and Hormonal Influence on Bone Health
         Rajesh Garg, MBBS
       • Ostoporosis and Rehabilitation: The Evidence
         Susan Bennett, PT, ED, NCS, MSCS
   4. Clinical Courses (Go back to top)
   1. Advances in MRI Imaging
      Anthony Traboulsee, MD, FRCPC
   2. Immunology of MS - Basic
      Avertano Noronha, MB, MD
   3. B Cell Immunology
      Emmanuelle Waubant, MD, PhD
      • B Cell Based Therapies for MS and Related Diseases
        Emmanuelle Waubant, MD, PhD
      • The Role of B Cells in MS: Human Health
        Anne Cross, MD
      • The Role of B Cells in MS: Clues from Animal Models
        Jeri-Anne Lyons, PhD
   4. Neuro-ophthalmology
      Robert Shin, MD; Janet Rucker, MD; Fiona Costello, MD
   5. Clinical Exercise Testing and Prescription for Persons with MS: A Practical Approach
      Eduard Gappmaier, PT, PhD
   6. Tech-Medicine in MS Care: New Frontiers
      Deborah Miller, PhD, LISW
      • What Can Tele-Health Do to Enhance MS Care? Experiences from the VA
        Jodie Haselkorn, MD, MPH
      • Mellen Center Care On-Line: A Health Services Experiment
        Deborah Miller, PhD, LISW
      • MS Tele-Health: Where We Are and Where We Are Going
        Robert Kane, PhD
   7. Neurology for the Non-Neurologists
      MS Clinical Syndromes: Assessment and Lesion Localization
      Lynn McEwan, RN, MScN, CNNS, MSCN
   8. Introduction to Grant Writing for Nurse Practitioners
      Jennifer Smrtka, RN, MSN, ANP-C; Amy Perrin-Ross, RN, APRN, MSN, CNRN, MSCN
   9. Technological Advances in Rehabilitation and Universal Design
      Patricia Provance, PT, MSCS
      • Ambulation and Power Mobility
        Patricia Provance, PT, MSCS
      • Technology, Design and Environmental Access
        Carrie Bruce, MA, CCC-SLP, ATP
      • Optimizing Independence Using Assistive Aids and Technology
        Additional Information - Resources
        Cindy Gackle, OTR/L, MSCS
   10. Cognition Evaluation: How to Identify Problems and Make Use of Test Results
       Jeffrey Wilken, PhD
       • Cognitive Dysfuntion in MS: How it Can be Identified in the Neurologist's Office
         Jeffrey Wilken, PhD
       • Standardized Cognitive Screens for Use in MS
         Cynthia Sullivan, PhD
       • Neuropsychological Assessment: Understanding Test Results and Making Use of the Report
         Jeffrey Wilken, PhD; Cynthia Sullivan, PhD
   11. Long-Term Efficacy of Disease Modifying Therapy
       Norman Kachuck, MD
       • Betaseron
         Guy Buckle, MD
       • Avonex
         Frederick Munschauer, MD
       • Rebif
         Mark Freedman, MD
       • Copaxone
         Robert Lisak, MD
   12. North American Research Committee on Multiple Sclerosis: What It Can Do For You
       Denise Campagnolo, MD, MS
       • Validation of the NARCOMS Registry
         Ruth Ann Marrie, MD, MS
       • How to Use the NARCOMS Registry: Practical Guidelines
         Tuula Tyry, PhD
   13. Defining Benign Multiple Sclerosis
       Joseph Herbert, MD
       • Historical Overview of Benign MS
         Joseph Herbert, MD
       • Evolution of Benign MS in the New York State Multiple Sclerosis Consortium
         Robert Zivadinov, MD, PhD
       • New Definitions and Clinical Implications of Benign MS
         Sean Pittock, MD
       • A Predictive Model of Benign MS
         Joseph Herbert, MD
   5. Whitaker Research Track (Go back to top)
      Michael Racke, MD
      • Effect of Deletion of IL-4 / IL-4Rα in Experimental Autoimmune Encephalomyelitis (EAE)
        Stefanie Gaupp
      • An RCT with Open-Label Extension of Sativex, in MS-related Central Pail
        David Rog
      • Are Symptoms Associated with Physical Activity in Multiple Sclerosis?
        Erin Snook, MS
      • Contrasting Roles of Axonal Degeneration in Autoimmune Versus Viral Models for MS
        Ikuo Tsunoda, MD, PhD
      • Antigen-Specific Treatment of EAE Reverses Myelin and Axonal Injry
        Chunhe Wang, PhD
      • Relating Sensorimotor Function and Tract Specific MRI in Multiple Sclerosis
        Kathleen Zackowski, PhD, OTR
      • Neuroprotection in MS
        Peter Calabresi, MD
      • Use of Daclizumab in MS
        Bibiana Bielekova, MD
      • Effects of Nataluzimab on CNS Immune Surveillance
        Olaf Stuve, MD, PhD
      • New Observations on Glatiramer Acetate
        Michael Racke, MD